This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.
This poster evaluates the impact on clinical outcomes of a pharmacist-led social determinants of health (SDOH) screening and intervention program within the rheumatoid arthritis population of a health system specialty…
Shields Health Solutions (“Shields” or the “Company”), the premier specialty pharmacy accelerator in the country, announced today that it is now operating as a private standalone company following its acquisition…
This poster evaluates the cimpact of an ACP program on third party pharmacy coverage determination outcomes for specialty oncology medications prescribed from these clinics.
This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led HCM clinical management program.
This poster evaluates existing oral oncology medication waste events among patients filling at a HSSP.
STOUGHTON, Mass. (May 13, 2025)–Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country announced it has partnered with Duke Health, a leading academic health system in North…